ClinConnect ClinConnect Logo
Search / Trial NCT02791854

Improving the Quality of Care for Adults With Inflammatory Bowel Disease

Launched by DARTMOUTH-HITCHCOCK MEDICAL CENTER · Jun 1, 2016

Trial Information

Current as of October 15, 2025

Enrolling by invitation

Keywords

ClinConnect Summary

This study is an observational registry called IBD Qorus. It aims to build an Inflammatory Bowel Disease Learning Health System by collecting health information from adults with Crohn’s disease, ulcerative colitis, or other inflammatory bowel diseases. Researchers will gather patient-reported outcomes and medical data from many U.S. care sites into a shared registry (IBD Plexus) and create real-time dashboards and reports to help patients and their clinicians plan care and support research. It’s about learning how to improve care over time, not testing a new medicine or device.

Who can join? Adults 18 to 99 years old with Crohn’s disease, ulcerative colitis, or IBD unclassified, who are treated at a participating IBD Qorus site and can give informed consent. Enrollment is by invitation, and participants will contribute health information through online tools and surveys that you can share securely with your care team. Participants are followed for up to 20 years, with key information checked annually for the first five years, including how many are in remission, steroid use, ER visits, hospitalizations, and problems like anemia or malnutrition. There are many participating centers across the United States. As of now, no results are available from this study.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 18 years of age or older
  • Diagnosis of Crohn's disease or ulcerative colitis or IBD unclassified
  • Accept the terms and conditions of Informed Consent and Authorization
  • Affiliated with a participating IBD Qorus site
  • Exclusion Criteria:
  • Inability to provide informed consent
  • Study key personnel cannot enroll as a study participant

About Dartmouth Hitchcock Medical Center

Dartmouth-Hitchcock Medical Center (DHMC) is a leading academic medical institution located in Lebanon, New Hampshire, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a major teaching hospital affiliated with the Geisel School of Medicine at Dartmouth, DHMC integrates cutting-edge clinical trials and translational research into its comprehensive patient care approach. The center emphasizes collaboration across disciplines, aiming to enhance patient outcomes through rigorous scientific investigation, education, and community engagement. With a focus on ethical practices and patient safety, DHMC is dedicated to contributing to the advancement of medical knowledge and improving health care delivery.

Locations

Charleston, South Carolina, United States

Jackson, Mississippi, United States

Rochester, New York, United States

New York, New York, United States

Dallas, Texas, United States

Atlanta, Georgia, United States

Tampa, Florida, United States

Charlottesville, Virginia, United States

Providence, Rhode Island, United States

New York, New York, United States

Salt Lake City, Utah, United States

Germantown, Tennessee, United States

Los Angeles, California, United States

Los Angeles, California, United States

Newport Beach, California, United States

San Diego, California, United States

Denver, Colorado, United States

New Haven, Connecticut, United States

Washington, District Of Columbia, United States

Miami, Florida, United States

Chicago, Illinois, United States

Chicago, Illinois, United States

Evansville, Indiana, United States

Kansas City, Kansas, United States

Shreveport, Louisiana, United States

Grand Rapids, Michigan, United States

Novi, Michigan, United States

Lebanon, New Hampshire, United States

Burnt Hills, New York, United States

Mineola, New York, United States

Portland, Oregon, United States

Hershey, Pennsylvania, United States

Lancaster, Pennsylvania, United States

Houston, Texas, United States

Seattle, Washington, United States

Boise, Idaho, United States

Grand Rapids, Michigan, United States

Mineola, New York, United States

Patients applied

0 patients applied

Trial Officials

Corey Siegel, MD, MS

Principal Investigator

Dartmouth-Hitchcock Medical Center

Gil Melmed, MD, MS

Principal Investigator

Cedars-Sinai Medical Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials